학술논문

Neoadjuvant Chemotherapy For Patients With Intrahepatic Cholangiocarcinoma: A Propensity-Score Matched Survival Analysis.
Document Type
Article
Source
HPB. 2020 Supplement, Vol. 22, pS28-S28. 1p.
Subject
*NEOADJUVANT chemotherapy
*SURVIVAL analysis (Biometry)
*CHOLANGIOCARCINOMA
*HOSPITAL utilization
Language
ISSN
1365-182X
Abstract
B Presenter: b Ovie Utuama MD | Moffitt Cancer Center B Background: b Although liver resection provides the only potentially-curative approach for management of intrahepatic cholangiocarcinoma (ICC), locoregional and systemic recurrence remain common. NC utilization overtime was evaluated across participating hospitals, and predictors of NC use were identified using multivariable logistic regression. Despite no clear survival benefit, this study shows that patients with more advanced disease may benefit from a multimodality approach using preoperative chemotherapy. [Extracted from the article]